Sinopharm Group Co. Ltd.
1099
株式のランク
#2955
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of... Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
株価
$2.00
時価総額
$6.23B
変化（1日）
1.56%
変化（1年）
-17.09%
国
CN
取引 Sinopharm Group Co. Ltd. (1099)
カテゴリー
Healthcare
Sinopharm Group Co. Ltd.（1099）の収益
Jun 2026 時点の収益 TTM: $82.31B
Sinopharm Group Co. Ltd. の最新の財務報告によると、現在の収益 (TTM) は $82.31B です。2023 年には $84.28B の収益があり、これは 2022 年の $80.05B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Sinopharm Group Co. Ltd. の収益履歴（2006 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $82.31B | 2.79% |
| 2024 | $80.08B | -4.98% |
| 2023 | $84.28B | 5.29% |
| 2022 | $80.05B | -2.36% |
| 2021 | $81.98B | 17.34% |
| 2020 | $69.87B | 14.40% |
| 2019 | $61.07B | 21.94% |
| 2018 | $50.09B | 17.63% |
| 2017 | $42.58B | 14.53% |
| 2016 | $37.18B | 5.57% |
| 2015 | $35.21B | 8.99% |
| 2014 | $32.31B | 17.45% |
| 2013 | $27.51B | 26.33% |
| 2012 | $21.78B | 34.29% |
| 2011 | $16.22B | 54.59% |
| 2010 | $10.49B | 52.22% |
| 2009 | $6.89B | 23.13% |
| 2008 | $5.60B | 31.35% |
| 2007 | $4.26B | 40.12% |
| 2006 | $3.04B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $410.98B | 399.29% |
US
|
|
| - | - |
US
|
|
| $254.25B | 208.88% |
US
|
|
| - | - |
US
|
|
| $7.64B | -90.72% |
AU
|
